Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POINT trial in new transient ischemic attack and minor ischemic stroke
2013-001185-41Phase 3Terminated
- Sponsor
- University of California, San Francisco
- Start
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in transient ischaemic attack (TIA) and ischemic stroke comparing Plavix + aspirin with Placebo + aspirin (2 arms). Primary endpoint: Primary efficacy endpoint. Started Dec 2013; status: terminated.
02
Drugs
clopidogrel
03
Conditions
transient ischaemic attack (TIA)ischemic stroke
Beyond the preview
Go deeper on 2013-001185-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001185-41.